Authors and Affiliates
Niklas Grassl 1,2,3, Isabel Poschke 1,4, Katharina Lindner 1,4, Lukas Bunse 1,2,3, Iris Mildenberger 1,2,3, Tamara Boschert 1,4,5, Kristine Jähne 1,2,3, Edward W Green 1,2,3, Ingrid Hülsmeyer 1,4, Simone Jünger 1,4, Tobias Kessler 6,7, Abigail K Suwala 8,9, Philipp Eisele 2, Michael O Breckwoldt 1,3,10, Peter Vajkoczy 11, Oliver M Grauer 12, Ulrich Herrlinger 13, Joerg-Christian Tonn 14, Monika Denk 15, Felix Sahm 8,9, Martin Bendszus 10, Andreas von Deimling 8,9, Frank Winkler 6,7, Wolfgang Wick 6,7, Michael Platten 16,17,18,19,20, Katharina Sahm 21,22,23;
1 DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
2 Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany.
3 DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.
4 Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
5 Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center, Mainz, Germany.
6 Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
7 National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
8 Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
9 DKTK Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
10 Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
11 Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
12 Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
13 Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany.
14 Department of Neurosurgery, University of Munich LMU, Munich, Germany.
15 Institute of Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
16 DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz-heidelberg.de.
17 Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany. m.platten@dkfz-heidelberg.de.
18 DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. m.platten@dkfz-heidelberg.de.
19 Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. m.platten@dkfz-heidelberg.de.
20 Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center, Mainz, Germany. m.platten@dkfz-heidelberg.de.
21 DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. k.sahm@dkfz-heidelberg.de.
22 Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany. k.sahm@dkfz-heidelberg.de.
23 DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.